The ability of SL7207/c-Myc to knockdown gene expression in vitro was assessed using confluent cultures of colorectal cancer (CRC) cell lines HCT116 and SW480 plus breast cancer line MCF7. This evidence concerns the gene MYC and breast carcinoma.